Clinical and Economic Evaluation of Rapid Influenza A Virus Testing in Nursing Homes in Calgary, Canada
Open Access
- 15 March 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 34 (6) , 790-795
- https://doi.org/10.1086/338960
Abstract
The incremental benefits and costs of a rapid influenza A virus infection diagnostic service were studied in nursing homes in Calgary, Canada, duringKeywords
This publication has 20 references indexed in Scilit:
- Chemoprophylaxis of Influenza A Virus Infections, with Single Doses of Zanamivir, Demonstrates that Zanamivir Is Cleared Slowly from the Respiratory TractAntimicrobial Agents and Chemotherapy, 1999
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997
- Effectiveness of Influenza Vaccine in the ElderlyGerontology, 1996
- The Efficacy of Influenza Vaccine in Elderly PersonsAnnals of Internal Medicine, 1995
- Control of Influenza Outbreaks in the Nursing Home: Guidelines for Diagnosis and ManagementJournal of the American Geriatrics Society, 1995
- The Impact and Cost of Influenza in the ElderlyArchives of internal medicine (1960), 1993
- Comparison of Pharmacokinetic and Safety Profiles of Amantadine 50‐ and 100‐mg Daily Doses in Elderly Nursing Home ResidentsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1991
- Occurrence of Adverse Effects and High Amantadine Concentrations With Influenza Prophylaxis in the Nursing HomeJournal of the American Geriatrics Society, 1990
- Mortality and InfluenzaThe Journal of Infectious Diseases, 1982
- Pneumonia and Influenza Deaths During EpidemicsArchives of internal medicine (1960), 1982